Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

523
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
523
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

67
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
67
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

697
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
697

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paclitaxel-Coated Balloon Versus Uncoated Balloon for Coronary In-Stent Restenosis: Two-Year Follow-Up of the AGENT-IDE Randomized Clinical Trial.

Circulation·2026
Same author

Understanding the mechanisms behind the annuloplasty effect in tricuspid valve TEER: a computational study.

Journal of biomechanics·2026
Same author

Impact of Revascularization Completeness on Cardiovascular Outcomes in STEMI With Multivessel Disease.

Circulation. Cardiovascular interventions·2026
Same author

Short Versus Extended Duration of Triple Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients Requiring Oral Anticoagulation: A Retrospective Single-Center Study.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Comparative Efficacy of Transfusion Strategies in Women and Men With Myocardial Infarction and Anemia: Prespecified Secondary Findings From the MINT Trial.

Circulation·2026
Same author

Latent Class Analysis Identifies Pulmonary Function Trajectory Phenotypes in Lung Transplant Recipients with Chronic Allograft Dysfunction.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: Jul 2, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.0K

Implementation of a Multidimensional Strategy to Reduce Post-PCI Bleeding Risk.

Andrea L Price1, Amit P Amin2, Susan Rogers3

  • 1Indiana University Health, Indianapolis (A.L.P.).

Circulation. Cardiovascular Interventions
|February 27, 2024
PubMed
Summary
This summary is machine-generated.

The American College of Cardiology

Keywords:
evidence based practicehealthcare deliveryhospitalspercutaneous coronary interventionquality improvement

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.3K
Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
13:48

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

Published on: April 21, 2023

1.5K

Related Experiment Videos

Last Updated: Jul 2, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.0K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.3K
Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
13:48

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

Published on: April 21, 2023

1.5K

Area of Science:

  • Cardiovascular Medicine
  • Quality Improvement Initiatives
  • Interventional Cardiology

Background:

  • The American College of Cardiology (ACC) launched the Reduce the Risk: PCI Bleed Campaign, a hospital-based quality improvement initiative.
  • The campaign aimed to decrease bleeding events following percutaneous coronary intervention (PCI).
  • It provided evidence-based tools for hospitals to adapt and implement.

Purpose of the Study:

  • To evaluate the effectiveness of the ACC Reduce the Risk: PCI Bleed Campaign.
  • To assess the association between campaign participation and post-PCI bleeding rates.
  • To compare bleeding outcomes in campaign participant hospitals versus non-participant hospitals.

Main Methods:

  • Utilized data from 8,757,737 procedures in the National Cardiovascular Data Registry (2015-2021).
  • Compared bleeding outcomes between 195 campaign hospitals and 1384 non-campaign hospitals.
  • Employed multivariable hierarchical logistic regression to analyze adjusted associations and examined prespecified subgroups.

Main Results:

  • Campaign participation was linked to a significant reduction in post-PCI bleeding (adjusted odds ratio, 0.61).
  • Hospitals participating in the campaign demonstrated a greater decrease in bleeding events compared to non-participants.
  • Reductions were observed in patients with non-ST-segment-elevation acute coronary syndrome and ST-segment-elevation myocardial infarction, but not in patients without acute coronary syndrome.

Conclusions:

  • Participation in the ACC Reduce the Risk: PCI Bleed Campaign significantly reduced post-PCI bleeding events.
  • National quality improvement efforts, like this campaign, can substantially impact PCI outcomes.
  • The findings highlight the success of targeted interventions in improving cardiovascular procedure safety.